Diagnosticos da America (DASA)
DASA3.SA
#6178
Rank
C$1.23 B
Marketcap
C$0.99
Share price
7.14%
Change (1 day)
89.22%
Change (1 year)

P/E ratio for Diagnosticos da America (DASA) (DASA3.SA)

P/E ratio as of December 2025 (TTM): -7.95

According to Diagnosticos da America (DASA)'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.94515. At the end of 2024 the company had a P/E ratio of -1.98.

P/E ratio history for Diagnosticos da America (DASA) from 2009 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-1.98-66.3%
2023-5.88-70.34%
2022-19.8-76.27%
2021-83.5-63.44%
2020-228-260.23%
2019142219%
201844.7-26.54%
201760.810.85%
201654.8-55.34%
2015123211.74%
201439.422.77%
201332.1-32.45%
201247.554.77%
201130.7-36.63%
201048.463.18%
200929.7-133.45%
2008-88.7-363.34%
200733.7-76.07%
2006141-31.77%
2005206

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.